Wells Fargo
ORKA

Wells Fargo’s Oruka Therapeutics ORKA Stock Holding History

Wells Fargo’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$727K Sell
14,831
-28,430
-66% -$988K ﹤0.01% 3935
2025
Q4 		$1.31M Buy
43,261
+22,405
+107% +$624K ﹤0.01% 3758
2025
Q3 		$401K Buy
20,856
+3,401
+19% +$50.4K ﹤0.01% 4459
2025
Q2 		$196K Buy
+17,455
New +$182K ﹤0.01% 4788
2024
Q2 		– Sell
-7
Closed -$279 – 6855
2024
Q1 		$141 Hold
7
– – ﹤0.01% 6583
2023
Q4 		$134 Buy
7
+1
+17% +$22 ﹤0.01% 6699
2023
Q3 		$151 Sell
6
-3
-33% -$73 ﹤0.01% 6649
2023
Q2 		$211 Buy
9
+1
+13% +$25 ﹤0.01% 6687
2023
Q1 		$199 Hold
8
– – ﹤0.01% 6773
2022
Q4 		$232 Hold
8
– – ﹤0.01% 6583
2022
Q3 		$0 Hold
8
– – ﹤0.01% 7522
2022
Q2 		$0 Buy
8
+1
+14% +$28 ﹤0.01% 7647
2022
Q1 		$0 Hold
7
– – ﹤0.01% 7978
2021
Q4 		$0 Hold
7
– – ﹤0.01% 7930
2021
Q3 		$0 Sell
7
-6
-46% -$222 ﹤0.01% 7633
2021
Q2 		$0 Buy
13
+8
+160% +$334 ﹤0.01% 7567
2021
Q1 		$0 Hold
5
– – ﹤0.01% 7492
2020
Q4 		$0 Buy
5
+2
+67% +$100 ﹤0.01% 7128
2020
Q3 		$0 Buy
3
+2
+200% +$141 ﹤0.01% 7023
2020
Q2 		$0 Hold
1
– – ﹤0.01% 6936
2020
Q1 		$0 Buy
+1
New +$54 ﹤0.01% 6924
2016
Q3 		– Sell
-1
Closed – – 6379
2016
Q2 		$0 Hold
1
– – ﹤0.01% 6371
2016
Q1 		$0 Hold
1
– – ﹤0.01% 6483
2015
Q4 		$1K Hold
1
– – ﹤0.01% 6120
2015
Q3 		$1K Hold
1
– – ﹤0.01% 6088
2015
Q2 		$1K Buy
+1
New +$1.31K ﹤0.01% 6267
2015
Q1 		– Hold
0
– – – 6402
2014
Q4 		– Hold
0
– – – 6457
2014
Q3 		– Hold
0
– – – 6382
2014
Q2 		– Hold
0
– – – 6325
2014
Q1 		– Hold
0
– – – 6113
2013
Q4 		– Hold
0
– – – 5962
2013
Q3 		– Hold
0
– – – 5877
2013
Q2 		– Hold
0
– – – 5719

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Wells Fargo's ORKA Position: Q1 2026 in Review

Wells Fargo reduced its Oruka Therapeutics (ORKA) stake by 66% in Q1 2026, selling an estimated $988K and leaving 14,831 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #3935.

Wells Fargo first reported a position in ORKA in Q2 2015 and has held it in 26 quarters since. The position peaked at $1.31M in Q4 2025. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Wells Fargo held 14,831 shares of Oruka Therapeutics worth $727K as of Q1 2026.
  • Wells Fargo sold 28,430 Oruka Therapeutics shares in Q1 2026, an estimated $988K.
  • Oruka Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3935 holding.
  • Wells Fargo first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 26 quarters since.
  • Wells Fargo's Oruka Therapeutics position peaked at $1.31M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.